IRIS

1.1 Articolo in rivista: [26919] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.801 a 12.820 di 26.919
Titolo Data di pubblicazione Autore(i) File
Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails 1-gen-2005 Sessa, C; De Braud, F; Perotti, A; Bauer, J; Curigliano, G; Noberasco, C; Zanaboni, F; Gianni, L; Marsoni, S; Jimeno, J; D'Incalci, M; Dall'O, E; Colombo, N
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group 1-gen-2018 Grignani, Giovanni; D'Ambrosio, Lorenzo; Pignochino, Ymera; Palmerini, Emanuela; Zucchetti, Massimo; Boccone, Paola; Aliberti, Sandra; Stacchiotti, Silvia; Bertulli, Rossella; Piana, Raimondo; Miano, Sara; Tolomeo, Francesco; Chiabotto, Giulia; Sangiolo, Dario; Pisacane, Alberto; Dei Tos, Angelo Paolo; Novara, Luca; Bartolini, Alice; Marchesi, Emanuela; D'Incalci, Maurizio; Bardelli, Alberto; Picci, Piero; Ferrari, Stefano; Aglietta, Massimo
The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts 1-gen-2013 Bello, E; Taraboletti, G; Colella, G; Zucchetti, M; Forestieri, D; Licandro, Sa; Berndt, A; Richter, P; D'Incalci, M; Cavalletti, E; Giavazzi, R; Camboni, G; Damia, G
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 1-gen-2020 Benvenuto, G; Todeschini, P; Paracchini, L; Calura, E; Fruscio, R; Romani, C; Beltrame, L; Martini, P; Ravaggi, A; Ceppi, L; Sales, G; Donati, F; Perego, P; Zanotti, L; Ballabio, S; Grassi, T; Delle Marchette, M; Tognon, G; Sartori, E; Adorni, M; Odicino, F; D'Incalci, M; Bignotti, E; Romualdi, C; Marchini, S.
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia 1-gen-2016 Mannarino, L; Paracchini, L.; Craparotta, I.; Romano, M.; Marchini, S.; Gatta, R.; Erba, E.; Clivio, L.; Romualdi, Chiara; D'Incalci, Maurizio; Beltrame, L.; Pattini, L.
Differences in docetaxel and paclitaxel activity in resistant tumor cells which express MRP: Need of comparative clinical trials in resistant patients 1-gen-1997 D'Incalci, M
Alpha 1 acid glycoprotein (AGP) binds to STI571 and alters its tissue distribution and intracellular concentrations 1-gen-2000 Gambacorti-Passerini, C; Zucchetti, M; Cleris, L; Rossi, F; Pogliani, E; Corneo, G; Formelli, F; D'Incalci, M
Effectiveness of ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells 1-gen-2002 Scotlandi, K; Perdichizzi, S; Manara, Mc; Serra, M; Benini, S; Cerisano, V; Strammiello, R; Mercuri, M; Reverter-Branchat, G; Faircloth, G; D'Incalci, M; Picci, P
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus 1-gen-2017 Vazquez, R; Riveiro, Me; Astorgues-Xerri, L; Odore, E; Rezai, K; Erba, E; Panini, N; Rinaldi, A; Kwee, I; Beltrame, L; Bekradda, M; Cvitkovic, E; Bertoni, F; Frapolli, R; D'Incalci, M
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors 1-gen-2009 Forni, C; Minuzzo, M; Virdis, E; Tamborini, E; Simone, M; Tavecchio, M; Erba, E; Grosso, F; Gronchi, A; Aman, P; Casali, P; D'Incalci, M; Pilotti, S; Mantovani, R
Effect of G:C->A:T transition, potentially arising from O-6-guanine alkylation, in the transcription regulation of c-fos serum response element 1-gen-1997 Bonfanti, M; Colella, G; Broggini, M; D'Incalci, M
Changes in the transcription regulation mediated by FUS-CHOP gene in a myxoid liposarcoma cell line resistant to trabectedin 1-gen-2010 Uboldi, S; Bernasconi, S; Romano, M; Marchini, S; Di Giandomenico, S; Damia, G; Ganzinelli, M; Galmarini, Cm; Erba, E; D'Incalci, M
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status 1-gen-1997 Defeudis, P; Debernardis, D; Beccaglia, P; Valenti, M; Sire, Eg; Arzani, D; Stanzione, S; Parodi, S; D'Incalci, M; Russo, P; Broggini, M
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 1-gen-2017 Todeschini, Paola; Salviato, Elisa; Paracchini, Lara; Ferracin, Manuela; Petrillo, Marco; Zanotti, Laura; Tognon, Germana; Gambino, Angela; Calura, Enrica; Caratti, Giulia; Martini, Paolo; Beltrame, Luca; Maragoni, Lorenzo; Gallo, Daniela; Odicino, Franco E.; Sartori, Enrico; Scambia, Giovanni; Negrini, Massimo; Ravaggi, Antonella; D'Incalci, Maurizio; Marchini, Sergio; Bignotti, Eliana; Romualdi, Chiara
Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral C-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors 1-gen-2006 Frapolli, R; Marangon, E; Zaffaroni, M; Colombo, T; Falcioni, C; Bagnati, R; Simone, M; D'Incalci, M; Manzotti, C; Fontana, G; Morazzoni, P; Zucchetti, M
Snail levels control the migration mechanism of mesenchymal tumor cells 1-gen-2016 Belgiovine, C; Chiesa, G; Chiodi, I; Frapolli, R; Bonezzi, K; Taraboletti, G; D'Incalci, M; Mondello, C
Unique features of the mode of action of ET-743 1-gen-2002 D'Incalci, M; Erba, E; Damia, G; Galliera, E; Carrassa, L; Marchini, S; Mantovani, R; Tognon, G; Fruscio, R; Jimeno, J; Faircloth, Gt
hMLH1 and hMSH2 expression and BAX frameshift mutations in ovarian cancer cell lines and tumors 1-gen-1998 Colella, G; Vikhanskaya, F; Codegoni, Am; Bonazzi, C; D'Incalci, M; Broggini, M
Differences between in vivo and in vitro sensitivity to imatinib of Bcr/Abl plus cells obtained from leukemic patients 1-gen-2002 Gambacorti-Passerini, Cb; Rossi, F; Verga, M; Ruchatz, H; Gunby, R; Frapolli, R; Zucchetti, M; Scapozza, L; Bungaro, S; Tornaghi, L; Rossi, F; Pioltelli, P; Pogliani, E; D'Incalci, M; Corneo, G
Gene expression profile of sensitive and resistant ovarian cancer cells treated with ET 743 1-gen-2001 Marchini, S; Chiorino, G; Cravello, B; Erba, E; D'Incalci, M; Broggini, M; Faircloth, Gt
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.801 a 12.820 di 26.919
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26919
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro723
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA457
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269123
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS228
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE184
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19415
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19197
  • ita408
  • spa14
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24666
  • reserved1362
  • open891